Cystic Fibrosis Stocks List

Recent Signals

Date Stock Signal Type
2021-04-14 CRBP Stochastic Reached Oversold Weakness
2021-04-14 CRBP 180 Bearish Setup Bearish Swing Setup
2021-04-14 ELMD Shooting Star Candlestick Bearish
2021-04-14 ELMD Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-14 ELMD Slingshot Bearish Bearish Swing Setup
2021-04-14 ELMD Stochastic Buy Signal Bullish
2021-04-14 ELMD Doji - Bearish? Reversal
2021-04-14 ELOX Jack-in-the-Box Bearish Bearish Swing Setup
2021-04-14 GILD Bollinger Band Squeeze Range Contraction
2021-04-14 GILD Crossed Above 200 DMA Bullish
2021-04-14 GILD Crossed Above 20 DMA Bullish
2021-04-14 GLPG Crossed Above 20 DMA Bullish
2021-04-14 GLPG Pocket Pivot Bullish Swing Setup
2021-04-14 KMDA Crossed Above 20 DMA Bullish
2021-04-14 KMDA Pocket Pivot Bullish Swing Setup
2021-04-14 KMDA Bollinger Band Squeeze Range Contraction
2021-04-14 PRQR 20 DMA Resistance Bearish
2021-04-14 PTCT Slingshot Bearish Bearish Swing Setup
2021-04-14 PTCT Shooting Star Candlestick Bearish
2021-04-14 PULM Lower Bollinger Band Walk Weakness
2021-04-14 PULM Stochastic Buy Signal Bullish
2021-04-14 PULM Jack-in-the-Box Bearish Bearish Swing Setup
2021-04-14 SVRA 50 DMA Resistance Bearish
2021-04-14 SVRA 1,2,3 Pullback Bullish Bullish Swing Setup
2021-04-14 TBIO Crossed Above 200 DMA Bullish
2021-04-14 TBIO Crossed Above 20 DMA Bullish
2021-04-14 VRNA 50 DMA Resistance Bearish
2021-04-14 VRNA MACD Bearish Signal Line Cross Bearish
2021-04-14 VRNA 20 DMA Resistance Bearish
2021-04-14 VRTX Shooting Star Candlestick Bearish
2021-04-14 VRTX Bollinger Band Squeeze Range Contraction
2021-04-14 VRTX Lizard Bearish Bearish Day Trade Setup

Recent News for Cystic Fibrosis Stocks

Date Stock Title
Apr 14 GILD U.S. in unique position to force increased accountability at the WHO: FDD
Apr 14 GLPG Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
Apr 14 GILD Gilead (GILD) Gets FDA Nod for Trodelvy in Urothelial Cancer
Apr 14 GILD Gilead’s Bladder Cancer Drug Trodelvy Gets FDA Nod
Apr 14 PTCT PTC Therapeutics Launches the PTC Pinpoint Direct™ Program for Patient-Initiated Genetic Testing
Apr 14 GILD A Peek Into The Markets: US Stock Futures Edge Higher; Bank Earnings In Focus
Apr 13 GILD U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer
Apr 13 PRQR ProQR's sepofarsen shows promise in blindness study
Apr 13 PRQR ProQR Announces Publication in Nature Medicine for Sepofarsen in Leber Congenital Amaurosis 10
Apr 13 GILD Gilead wins FDA accelerated approval for Trodelvy in urothelial cancer
Apr 13 GILD How COVID-19 transformed the biotech industry
Apr 13 GILD Gilead halts remdesivir trial in high-risk COVID-19 patients
Apr 13 VRTX 5 Value Stocks With 26% to 50% Upside, According to Wall Street
Apr 13 GNMK INVESTIGATION ALERT: Halper Sadeh LLP Investigates LMNX, NUAN, CADE, GNMK; Shareholders are Encouraged to Contact the Firm
Apr 12 GNMK SHAREHOLDER ALERT: WeissLaw LLP Reminds GNMK, LDKB, PBCT, and CTB Shareholders About Its Ongoing Investigations
Apr 12 PULM Corrected: Pulmatrix to Regain Full Rights to PUR1800 and Narrow Spectrum Kinase Inhibitor Portfolio
Apr 12 PULM Pulmatrix slips 15% after J&J terminates license agreement
Apr 12 PULM Pulmatrix Stock Is Trading Lower After JNJ's Lung Cancer Initiative Terminates PUR1800 Licensing Pact
Apr 12 GNMK INVESTIGATION ALERT: Halper Sadeh LLP Investigates CLGX, KSHB, AEGN, GNMK; Shareholders Are Encouraged to Contact the Firm
Apr 12 PULM Pulmatrix to Regain Full Rights to PUR1800 and Narrow Spectrum Kinase Inhibitor Portfolio

Cystic fibrosis (CF) is a genetic disorder that affects mostly the lungs, but also the pancreas, liver, kidneys, and intestine. Long-term issues include difficulty breathing and coughing up mucus as a result of frequent lung infections. Other signs and symptoms may include sinus infections, poor growth, fatty stool, clubbing of the fingers and toes, and infertility in most males. Different people may have different degrees of symptoms.CF is inherited in an autosomal recessive manner. It is caused by the presence of mutations in both copies of the gene for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Those with a single working copy are carriers and otherwise mostly normal. CFTR is involved in production of sweat, digestive fluids, and mucus. When the CFTR is not functional, secretions which are usually thin instead become thick. The condition is diagnosed by a sweat test and genetic testing. Screening of infants at birth takes place in some areas of the world.There is no known cure for cystic fibrosis. Lung infections are treated with antibiotics which may be given intravenously, inhaled, or by mouth. Sometimes, the antibiotic azithromycin is used long term. Inhaled hypertonic saline and salbutamol may also be useful. Lung transplantation may be an option if lung function continues to worsen. Pancreatic enzyme replacement and fat-soluble vitamin supplementation are important, especially in the young. Airway clearance techniques such as chest physiotherapy have some short-term benefit, but long-term effects are unclear. The average life expectancy is between 42 and 50 years in the developed world. Lung problems are responsible for death in 80% of people with cystic fibrosis.CF is most common among people of Northern European ancestry and affects about one out of every 3,000 newborns. About one in 25 people is a carrier. It is least common in Africans and Asians. It was first recognized as a specific disease by Dorothy Andersen in 1938, with descriptions that fit the condition occurring at least as far back as 1595. The name "cystic fibrosis" refers to the characteristic fibrosis and cysts that form within the pancreas.

More about Cystic Fibrosis
Browse All Tags